Douglas W. Pagan

Chief Financial Officer, Paratek Pharmaceuticals, Inc.

Companies

Kailera Therapeutics, Inc.Chief financial officer Apr 16, 2026 to now¹
Dicerna Pharmaceuticals (United States)Chief financial officer Jun 2, 2020 to Dec 29, 2021²
ZIOPHARM OncologyBoard member Sep 20, 2018 to Jan 3, 2020³
Paratek Pharmaceuticals, Inc.Chief financial officer Dec 22, 2014 to Apr 8, 2019⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Dicerna Pharmaceuticals (United States)0 shares⁵Dec 28, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 28, 2021U 7,775 shares at $38.25 of Dicerna Pharmaceuticals (United States)⁵
Dec 15, 2021Shares withheld for tax 602 shares at $38.05 of Dicerna Pharmaceuticals (United States)⁶
Dec 15, 2021Exercised options 2,050 shares of Dicerna Pharmaceuticals (United States)⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKailera Therapeutics, Inc., Chief financial officer
2
SEC EDGARDicerna Pharmaceuticals (United States), Chief financial officer
3
SEC EDGARZIOPHARM Oncology, Board member
4
SEC EDGARParatek Pharmaceuticals, Inc., Chief financial officer
5
SEC EDGARDicerna Pharmaceuticals (United States) shares after the filing of Dec 28, 2021
6
SEC EDGARForm 4 filed Dec 17, 2021